Tapak liman (Elephantopus scaber L.) dan sambiloto (Andrographis paniculata Nees) merupakan tanaman yang secara empiris digunakan untuk penyakit hati. Penelitian bertujuan untuk mengetahui efek hepatoprotektif pemberian kombinasi infusa akar tapak liman dan daun sambiloto. Tiga puluh enam tikus dibagi kedalam 6 kelompok secara acak. Kelompok I (kontrol normal), kelompok II (kontrol induksi), kelompok III (tapak liman 400 mg/200 g bb), kelompok IV (sambiloto 100 mg/200g bb), kelompok V (kombinasi tapak liman 400 mg dan sambiloto 50 mg), dan kelompok VI (kombinasi tapak liman 200 mg dan sambiloto 100 mg). Bahan uji diberikan peroral selama 8 hari dan 2 jam setelah pemberian terakhir karbon tetraklorida diberikan melalui rute yang sama. Pada hari ke-9 dilakukan pengambilan darah dan hati. Pengukuran aktivitas ALT dan ALP plasma menggunakan ALT dan ALP kit dan ditunjukan dengan perbedaan serapan. Analisa histologi didasarkan pada diameter vena sentralis dan persen kerusakan lobulus hati. Hasil menunjukan kelompok V dan VI berbeda bermakna dengan kelompok induksi untuk aktivitas ALT, ALP plasma serta hasil pengamatan histologi hati. Berdasarkan hasil dapat disimpulkan bahwa kombinasi infusa tapak liman dan sambiloto memiliki efek hepatoprotektif. Dosis kombinasi dengan hasil yang paling mendekati kontrol normal adalah kombinasi akar tapak liman 400 mg/200 g bb dan sambiloto 50 mg/200 g bb.

---

Tapak liman (Elephantopus scaber L.) and sambiloto (Andrographis paniculata Nees) were the plants empirically used in the treatment of liver disease. The aims of the study was to determine the hepatoprotective effect of infusa of tapak liman roots and sambiloto leaves combination. Thirty six male Sprague-Dawley rats were randomly divided into 6 groups. Group I (normal control), group II (induction control), group III (400mg/200g tapak liman), IV (100mg/200g sambiloto), V (400mg tapak liman and 50mg sambiloto), and VI (200mg tapak liman and 100mg sambiloto). The infusa were administered for 8 days and carbon tetrachloride was given 2 hours after the last administration. Collection of the blood and liver resection were carried out on 9th day. ALT and ALP plasma activities were analyzed using kit reagen and showed by absorbances differences. Diameter of liver central vein and liver lobules damage percentages were histological analysis parameter. There were significant differences between group V and VI with induction control for ALT, ALP activities supported by the results of liver histological examination. It can be concluded that the combination of tapak liman and sambiloto infusa had hepatoprotective effect and combination of 400mg tapak liman and 50mg sambiloto results were almost equivalent to normal control.